Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer

Prediction of outcome in patients with metastatic breast cancer remains problematical. The present study evaluated the value of an inflammation-based score (Glasgow Prognostic Score, GPS) in patients with metastatic breast cancer. The GPS was constructed as follows: patients with both an elevated C-...

Descripción completa

Detalles Bibliográficos
Autores principales: Murri, A M Al, Bartlett, J M S, Canney, P A, Doughty, J C, Wilson, C, McMillan, D C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361117/
https://www.ncbi.nlm.nih.gov/pubmed/16404432
http://dx.doi.org/10.1038/sj.bjc.6602922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361117/
https://www.ncbi.nlm.nih.gov/pubmed/16404432
http://dx.doi.org/10.1038/sj.bjc.6602922

Ejemplares similares